Terafab and Optimus Are Eating the Humanoid Robot Story From Both Ends

Elon Musk announced Terafab — a Tesla/SpaceX chip fabrication venture in Austin targeting AI, robotics, and data center infrastructure — and the coverage treated it like a moon landing. News outlets ran the announcement largely straight, and optimists on X were already comparing the vertical integration play to Google's TPU bet. On Bluesky, the response was more measured: a few posts noted that Musk himself described the manufacturing pace as "far slower than we'd hoped," a qualifier that got buried in most headlines.

That gap is the story right now. The humanoid robotics conversation has roughly tripled in volume over the past 24 hours, driven equally by Terafab and by a steady drip of Optimus content — shirt-folding videos, a dancing clip that Musk shared and which promptly went semi-viral, and a wave of comparative coverage pitting Optimus Gen 2 against Boston Dynamics Atlas, Agility Robotics Digit, and Unitree G1. News sentiment is running warm, closer to celebration than analysis. Bluesky is slightly negative in aggregate, though "negative" undersells it — the posts there aren't outraged so much as quietly skeptical, the kind of skepticism that doesn't make noise.

The more interesting thread is the one almost nobody is pulling. A post on Bluesky this week noted that a humanoid robot had learned to return tennis shots with 97% accuracy using five hours of amateur motion capture footage. The author's point wasn't the capability — it was what the training cost implies about how fast the economics of robotics are shifting, and how little of that implication is making it into mainstream coverage. That post had no likes. The Optimus dancing video had a frenzy. This is not a coincidence; it's an editorial choice the internet is making collectively, and it shapes which questions get asked.

Unitree's IPO is getting framed as a market maturation signal, China's humanoid advances are being called "simply mindblowing" by state-adjacent outlets, and NVIDIA quietly unveiled healthcare robotics models — GR00T-H and Rheo — without generating anything close to the attention Optimus gets for folding laundry. The $38 billion humanoid market figure is now circulating in headlines as settled fact rather than projection. When a forecast becomes a headline noun, the conversation has already moved past scrutiny into salesmanship.

What's worth watching is whether Terafab's chip ambitions actually reshape the competitive landscape or become another Musk announcement that the news cycle outpaces. The vertical integration logic is real — custom silicon does change what's possible in robotics inference, as Google's TPU history shows. But the same announcement contains the admission that manufacturing is running behind schedule, and that detail has a way of resurfacing badly when timelines slip further. The people on Bluesky who noticed it this week won't let it go when it matters.